The Ministry of Food and Drug Safety (MFDS), South Korea is holding a bilateral collaboration meeting with the Drug Administration of Vietnam (DAV), a regulatory authority under the Ministry of Health ...
China’s NMPA has cleared an adaptive seamless Phase II/III study of the selective oral small-molecule inhibitor for non-segmental vitiligo. Accro Bioscience and Fosun Pharma are preparing to advance ...
Sartorius and France-based MAbSilico have entered a non-exclusive collaboration combining AI-powered predictive algorithms from MAbSilico with cell line development (CLD) capabili ...
When we designed the small animal holding facility in 2012, we were solving a problem most facility planners preferred to defer: what happens when research needs change, but the walls cannot move? At ...
By adding Parafilm M to its portfolio, Avantor India enables customers to source the product alongside chemicals, reagents, ...
For decades, the complexity of the brain, limited understanding of disease biology and the formidable blood-brain barrier ...
Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, an ...
AABB has published a special TRANSFUSION journal supplement examining the growing biotherapies landscape, including cell and ...
The bottleneck is the specialist appointment More than 240 million people aged 65 and over live in the Western Pacific, a ...
For instance, in March 2026, China’s National Medical Products Administration (NMPA) announced approval of the country's ...
The gut-brain axis is moving from an emerging research concept towards a potential platform for precision mental health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results